News

Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.
Editas Medicine, Inc. (NASDAQ:EDIT) ranks among the best CRISPR stocks to buy. At the European Hematology Association 2025 ...
What was supposed to be a five-year, $750,000 NIH grant to fund Dr. Charity Oyedeji's sickle cell research at Duke University ...
A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding ...
Dr. Elizabeth Disbrow, the director for the Center for Brain Health at LSU Health Shreveport, joined KSLA on June 26 to ...
A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding cut, justified by NIH as a move against diversity, equity, and inclusion ...
A doctor says she’s scrambling to figure out how she’ll continue her work helping sickle cell disease patients after the ...
Considering a change to your treatment regimen? Columnist Mary Shaniqua shares tips to help patients and providers make an ...
Former Black Panther Party members share their reflections on the organization's legacy and lasting impacts of their social activism.
This article discusses how racial categories, rooted in social history, are used in records and society. It argues race isn’t ...
The Trump administration eliminated the CDC team that developed national guidelines for prescribing contraception safely for ...
Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...